Shukra Pharmaceuticals Limited has received a Letter of Intent (LoI) from the Yamuna Expressway Industrial Development Authority (YEIDA) for the allotment of 10 acres of land at the Medical Devices Park, marking a significant step in Uttar Pradesh’s growing medical technology ecosystem.
The proposed facility forms part of a planned ₹587 crore investment and is aligned with the state government’s broader strategy to position Uttar Pradesh as a key hub for medical devices manufacturing and healthcare innovation. The development is being driven under the leadership of Chief Minister Yogi Adityanath and supported by Invest UP, the state’s investment promotion agency.
The project is expected to strengthen domestic manufacturing capabilities in the medical technology sector while improving access to affordable and advanced healthcare solutions across India. By expanding its footprint at the YEIDA MedTech Park, Shukra Pharmaceuticals aims to contribute to India’s self-reliance goals in medical devices and healthcare infrastructure.
Senior officials from YEIDA, including Rakesh Kumar Singh, Chief Executive Officer, and Shailendra Bhatia, Additional Chief Executive Officer, were involved in facilitating the allotment process. The initiative was led internally by Shukra Pharmaceuticals’ senior leadership team, including Dr. Minakshi Late, CEO and Global Head, Gaurav Shokeen, Chief Operating Officer, Anil Kumar Verma, Vice President, and Kamini Bharti, Business Unit Head.
The upcoming facility at the Medical Devices Park is expected to play a role in enhancing India’s med-tech manufacturing capacity, supporting innovation, employment generation, and improved healthcare delivery, while contributing to the national vision of Aatmanirbhar Bharat.
